Johnson & Johnson (JNJ)
151.06
-0.21
(-0.14%)
USD |
NYSE |
May 21, 10:53
Johnson & Johnson Cash from Investing (TTM): -2.901B for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -2.901B |
December 31, 2023 | 878.00M |
September 30, 2023 | -2.317B |
June 30, 2023 | -6.559B |
March 31, 2023 | -5.422B |
December 31, 2022 | -12.37B |
September 30, 2022 | -13.33B |
June 30, 2022 | -14.35B |
March 31, 2022 | -12.13B |
December 31, 2021 | -8.683B |
September 30, 2021 | -11.23B |
June 30, 2021 | -13.33B |
March 31, 2021 | -20.43B |
December 31, 2020 | -20.82B |
September 30, 2020 | -14.27B |
June 30, 2020 | -11.09B |
March 31, 2020 | -5.358B |
December 31, 2019 | -6.194B |
September 30, 2019 | -2.622B |
June 30, 2019 | -5.246B |
March 31, 2019 | -3.659B |
December 31, 2018 | -3.167B |
September 30, 2018 | -5.90B |
June 30, 2018 | -2.811B |
March 31, 2018 | -14.86B |
Date | Value |
---|---|
December 31, 2017 | -14.87B |
September 30, 2017 | -16.54B |
June 30, 2017 | -17.73B |
March 31, 2017 | -4.16B |
December 31, 2016 | -4.761B |
September 30, 2016 | -3.978B |
June 30, 2016 | -2.607B |
March 31, 2016 | -7.483B |
December 31, 2015 | -7.735B |
September 30, 2015 | -9.266B |
June 30, 2015 | -7.53B |
March 31, 2015 | -12.07B |
December 31, 2014 | -12.30B |
September 30, 2014 | -10.96B |
June 30, 2014 | -13.25B |
March 31, 2014 | -5.726B |
December 31, 2013 | -5.103B |
September 30, 2013 | -6.028B |
June 30, 2013 | -6.412B |
March 31, 2013 | -9.969B |
December 31, 2012 | -4.51B |
September 30, 2012 | 4.231B |
June 30, 2012 | 4.578B |
March 31, 2012 | -1.996B |
December 31, 2011 | -4.612B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-20.82B
Minimum
Dec 2020
878.00M
Maximum
Dec 2023
-9.389B
Average
-9.888B
Median
Cash from Investing (TTM) Benchmarks
Amgen Inc | -27.78B |
Eli Lilly and Co | -7.642B |
Merck & Co Inc | -13.10B |
Pfizer Inc | -33.86B |
Shockwave Medical Inc | -716.36M |